We therefore measured IFN-γ and IL-2 production by PBMC and UC-3 tumor cells in the presence of VAR2, V-aCD3, aCD3 and a commercially available anti-CD3 monoclonal antibody (OKT3) (Fig. 4A, B). This evidence concerns the gene IFNG and neoplasm.